0001203311-16-000078.txt : 20160323
0001203311-16-000078.hdr.sgml : 20160323
20160323194408
ACCESSION NUMBER: 0001203311-16-000078
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160321
FILED AS OF DATE: 20160323
DATE AS OF CHANGE: 20160323
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SIEGALL CLAY B
CENTRAL INDEX KEY: 0001167496
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 161525169
MAIL ADDRESS:
STREET 1: 21823 30TH DR SE
CITY: BOTHELL
STATE: WA
ZIP: 98021
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2016-03-21
0
0001060736
SEATTLE GENETICS INC /WA
SGEN
0001167496
SIEGALL CLAY B
21823 30TH DRIVE SE
BOTHELL
WA
98021
1
1
0
0
President and CEO
Common Stock
2016-03-21
4
M
0
4282.0
4.45
A
560397
D
Common Stock
2016-03-21
4
S
0
4282.0
35.01
D
556115
D
Common Stock
2016-03-22
4
M
0
10954.0
4.45
A
567069
D
Common Stock
2016-03-22
4
S
0
10054.0
35.6868
D
557015
D
Common Stock
2016-03-22
4
S
0
900.0
36.1356
D
556115
D
Common Stock
27945
I
by Trust
Non-Qualified Stock Option (right to buy)
4.45
2016-03-21
4
M
0
4282.0
0.0
D
2016-09-05
Common Stock
4282
56655
D
Non-Qualified Stock Option (right to buy)
4.45
2016-03-22
4
M
0
10954.0
0.0
D
2016-09-05
Common Stock
10954
45701
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Sale price represents a weighted average price for all shares sold on this day, which are within a $1.00 range.
Sale price represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 3 to this Form 4.
Sale price represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 4 to this Form 4.
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
Shares vested at a rate of 25% on 9/06/07 and monthly thereafter until all the shares were fully vested on 9/06/10.
/s/ Clay B. Siegall
2016-03-23